Attenuated Clinical Phenotypes in Individuals with Larger Deletions of the APC 1A Transcript

CGA-IGC 2026

Nov 02, 2026
Oncology
Presentation

Colin Young, Kristin Kohler, Jamie Weyandt

Background and Aim
Heterozygous loss-of-function variants in APC cause familial adenomatous polyposis (FAP). Alternate 1A and 1B promoters generate distinct APC transcripts, with promoter 1A generally considered the primary driver of FAP phenotype. We investigated two gross deletions predicted to disrupt the 1A isoform in individuals with unexpectedly attenuated or absent FAP phenotypes.

 

Clinical Presentation
We identified two large deletions of coding exons 1-5 (Ex1_5del) and 1-7 (Ex1_7del) in the APC 1A transcript in two probands undergoing hereditary cancer panel testing. Neither individual reported a prior history of colon polyps at the time of testing. One proband was subsequently found to have 12 polyps in their 50s, consistent with attenuated FAP, while the second had a negative colonoscopy in their late 20s but a parental history of 10-19 colorectal polyps. These findings may be suggestive of an attenuated phenotype, and are not consistent with complete loss of APC function.

 

Discussion
MLPA demonstrated that both deletions disrupt the 1A promoter and translational start site while not impacting the 1B promoter/start codon. RNA studies identified substantial in-frame transcripts arising from the alternative 1B start site/first coding exon. These data suggest partial rescue of APC function through the 1B-driven transcription and support the possibility that transcripts lacking coding exons 2-7 of the 1B transcript may retain at least partial tumor suppressor function.

 

Conclusion
Evaluating effects on both 1A and 1B transcripts may improve APC variant interpretation and explain phenotypic differences between variants affecting one versus both isoforms. Additional tissue-specific and allele-specific expression studies may further refine FAP/CRC risk estimates associated with promoter-specific alterations.